Proscia is developing an algorithm that would give doctors a new way to predict (and prevent) the spread of cancer.
The startup launched by Johns Hopkins grads has a new partnership with Samsung Medical Center. The aim is to develop an algorithm that could predict the likelihood of metastasis, which is when cancer cells break away from a lung tumor and grow in the lymph nodes, said Proscia CEO David West.
According to a statement from Dr. Insuk Sohn, chief senior researcher at Samsung Medical Center, there is currently no way to accurately determine whether metastasis is likely. With such a method, they could have a better sense for which patients would benefit the most from undergoing a procedure that removes cancer tissue.
West said specialists at the South Korean-based research institute will provide datasets and other clinical data, and Proscia’s team will look to train its system to the point where it can be used as a diagnostic test. The two teams hope to develop a pipeline with lung cancer, then continue working together to address other types of cancers, West said. Proscia has also worked on lymph node metastasis of breast cancer.
“There is a predictive aspect of this,” West said. “The algorithm is designed to look at the image and look at pattern and make a prediction about the cancer spreading.”
Work on the algorithm is part of Proscia’s wider effort to develop a platform that brings digital tools to the work of diagnosing cancer, which is known as pathology. It’s a big leap for a field that relies on doctors analyzing slides through microscopes.
The Spark-based company closed a $1 million seed round in June 2016, and quickly expanded its dev team. In October, the company released a trio of image analysis tools. Proscia recently earned a nod on our realLIST of local startups to watch.
“We very much believe that the use of not just computer based image analysis tools but the really intelligent machine learning-based, cancer-specific diagnostics is the future of digital pathology,” West said.
Mental health startup Rose brings tech tools to Baltimore Neighbors Network connecting volunteers and seniors
Wound care startup Tissue Analytics was acquired by Pittsburgh’s Net Health. Here’s what it means for Baltimore
PGDx received FDA clearance for its genomic cancer diagnostic kit. It’s the first for a test of its kind
Audacious Inquiry brings APIs to the fight against COVID-19
Sign-up for daily news updates from Technical.ly Baltimore